These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20690346)

  • 1. Cardiovascular disease risk profile tools and new zealand--the best way forward?
    Boland P; Moriarty H
    J Prim Health Care; 2009 Dec; 1(4):328-31. PubMed ID: 20690346
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forward.
    Wells S; Riddell T; Jackson R
    J Prim Health Care; 2010 Jun; 2(2):168-9. PubMed ID: 20695051
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trading PREDICTions.
    Cox B
    N Z Med J; 2007 Sep; 120(1261):U2707. PubMed ID: 17853929
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. See-sawing cardiovascular risk factors: a call for action in New Zealand.
    White H
    N Z Med J; 2006 Nov; 119(1245):U2307. PubMed ID: 17146482
    [No Abstract]   [Full Text] [Related]  

  • 7. Documentation of cardiovascular risk factors.
    McBain L
    N Z Med J; 2008 Mar; 121(1270):106. PubMed ID: 18364763
    [No Abstract]   [Full Text] [Related]  

  • 8. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U663. PubMed ID: 14615805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Māori health outcomes with decision support.
    Hider P
    N Z Med J; 2007 Mar; 120(1250):U2443. PubMed ID: 17339899
    [No Abstract]   [Full Text] [Related]  

  • 10. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U662. PubMed ID: 14615804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaps in primary care documentation of cardiovascular risk factors.
    Rafter N; Wells S; Stewart A; Selak V; Whittaker R; Bramley D; Roseman P; Furness S; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):24-33. PubMed ID: 18278079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond.
    Ellis CJ; Hamer AW
    N Z Med J; 2008 Feb; 121(1269):5-10. PubMed ID: 18278077
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T; Jackson RT; Wells S; Broad J; Bannink L
    N Z Med J; 2007 Mar; 120(1250):U2445. PubMed ID: 17339901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G; Metcalf PA; Gentles D; Scragg RK; Schaaf D; Dyall L; Black P; Jackson R
    N Z Med J; 2008 Sep; 121(1281):28-39. PubMed ID: 18797481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand.
    Muir LA; George PM; Laurie AD; Reid N; Whitehead L
    N Z Med J; 2010 Nov; 123(1326):97-102. PubMed ID: 21326404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the lifetime cardiovascular risk of New Zealanders.
    Stewart RA; White HD
    N Z Med J; 2007 Sep; 120(1261):U2708. PubMed ID: 17853930
    [No Abstract]   [Full Text] [Related]  

  • 17. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and cardiovascular risk of new cases of type 2 diabetes in Otago, New Zealand, 1998-2004.
    Coppell K; Williams S; Anderson K; Lamb C; Mann J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):396-401. PubMed ID: 18990463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.